Exebio Joel C, Ajabshir Sahar, Campa Adriana, Li Tan, Zarini Gustavo G, Huffman Fatma G
Dietetics and Nutrition Department, Robert Stempel College of Public Health and Social Work, Florida International University, USA.
Dietetics and Nutrition Department, School of Allied Health, Keiser University, USA.
Int J Diabetes Clin Res. 2018;5(3). doi: 10.23937/2377-3634/1410093. Epub 2018 Sep 29.
Vitamin D deficiency and type 2 diabetes are common among Hispanics and African Americans in the US. The aim of the study was to determine the effect of supplemental vitamin D intake (4000 IU/day or 6000 IU/day of vitamin D3 over a 6-month period) on blood lipids in a sample of African Americans and Hispanics with type 2 diabetes and vitamin D insufficiency.
Participants (n = 75) were recruited by community outreach. Participants in both groups were required to take either 4000 IU or 6000 IU of vitamin D (Cholecalciferol) per day given in the form of a pill in a single daily dose. Mixed model was used to compare treatment effects (4000 IU vs. 6000 IU) on the outcome variables. Bonferroni multiple comparison test was used to detect significant changes from baseline, 3 months, and 6 months.
A significant decrease in total cholesterol (from 193.88 ± 41.03 to 180.48 ± 27.53 mg/dl, = 0.040) and triglycerides (from 201.44 ± 91.35 to 172.92 ± 76.87 mg/dl, = 0.037) was found for the 6000 IU group at 6 months. The significance was lost after adjusting for confounders.
Our results suggest that the positive effect of vitamin D supplementation on lipid profile may be mediated by other cofactors related to vitamin D metabolism among Hispanic and African American participants with type 2 diabetes.
维生素D缺乏和2型糖尿病在美国的西班牙裔和非裔美国人中很常见。本研究的目的是确定补充维生素D摄入量(在6个月期间每天摄入4000国际单位或6000国际单位的维生素D3)对患有2型糖尿病和维生素D不足的非裔美国人和西班牙裔样本血脂的影响。
通过社区宣传招募参与者(n = 75)。两组参与者都被要求每天服用4000国际单位或6000国际单位的维生素D(胆钙化醇),以药丸形式每日单剂量服用。使用混合模型比较治疗效果(4000国际单位与6000国际单位)对结果变量的影响。使用Bonferroni多重比较检验来检测基线、3个月和6个月时的显著变化。
6000国际单位组在6个月时总胆固醇(从193.88±41.03降至180.48±27.53毫克/分升,P = 0.040)和甘油三酯(从201.44±91.35降至172.92±76.87毫克/分升,P = 0.037)显著降低。在调整混杂因素后,这种显著性消失。
我们的结果表明,在患有2型糖尿病的西班牙裔和非裔美国参与者中,补充维生素D对血脂谱的积极作用可能由与维生素D代谢相关的其他辅助因素介导。